#18: BTIM Stock: BioTime CEO Dr. Michael West Presents Keynote Address at Event Commemorating the 10th Anniversary of the First Derivation of Human Embryonic Stem Cells
BioTime, Inc. (OTCBB:BTIM stock) Chief Executive Officer Michael West, Ph.D.
will deliver a keynote presentation on Wednesday, November 19, at a
meeting in Madison, Wisconsin...
BioTime, Inc. (OTCBB:BTIM stock) and the International
Longevity Center-USA today announced a collaboration aimed at
research, education and advocacy for regenerative medicine and...
Embryonic Stem Cell Research Discussed in Biotechnology
``Visionaries'' Panel
BioTime, Inc. (OTCBB:BTIM) Chief Executive Officer Michael West, PhD
today gave a...
BioTime Opens New GMP Laboratory for Production of Embryonic Stem Cell Technology Products
BioTime, Inc. (OTCBB:BTIM) announced today that it has opened an 11,000
square foot...
BioTime, Inc. (OTCBB:BTIM) announced its plan to build a relational database for its Embryome Sciences subsidiary that will display information useful in identifying the hundreds of cell types that...
BioTime, Inc. (OTCBB:BTIM) today announced that it has organized a new
subsidiary, Embryome Sciences, Inc. The mission of the new company is to
participate in the emerging field of...
EMERYVILLE, Calif.--(BUSINESS WIRE)--BioTime, Inc. (OTCBB:BTIM) announced today that a Phase II clinical
trial for Hextend® is being conducted in Japan
by Summit Pharmaceuticals...
EMERYVILLE, Calif.--(BUSINESS WIRE)--BioTime, Inc. (OTCBB:BTIM) today announced financial results for the
third quarter ended September 30, 2006. Revenues for the three months
ended...
EMERYVILLE, Calif.--(BUSINESS WIRE)--Aug. 16, 2006--BioTime, Inc. (OTCBB:BTIM): -- Receives payment of $500,000 for China and Taiwan licenses -- 94% Increase in Royalties on Hextend Sales to be...
EMERYVILLE, Calif.--(BUSINESS WIRE)--Dec. 22, 2005--BioTime, Inc. (OTCBB:BTIM) announced the completion of its subscription rights offer which expired at 5:00 p.m. New York time on December 21,...
EMERYVILLE, Calif.--(BUSINESS WIRE)--Dec. 20, 2005--BioTime, Inc. (OTCBB:BTIM) announced today that it has entered into an addendum to its agreement with Summit Pharmaceuticals International...
EMERYVILLE, Calif.--(BUSINESS WIRE)--Nov. 29, 2005--BioTime, Inc. (OTCBB:BTIM) today announced that it has amended the terms of its subscription rights offer by reducing the subscription price and...
EMERYVILLE, Calif.--(BUSINESS WIRE)--Nov. 15, 2005--BioTime, Inc. (OTCBB:BTIM): -- 41% Increase in Total Revenue -- Receives Payment of $247,000 under Joint Overseas Development Agreement...
EMERYVILLE, Calif.--(BUSINESS WIRE)--Oct. 27, 2005--BioTime, Inc. (OTCBB:BTIM) announced today that it commenced its rights offer under which it will distribute subscription rights ("Rights") to...
EMERYVILLE, Calif.--(BUSINESS WIRE)--Sept. 1, 2005--BioTime, Inc. (OTCBB:BTIM) announced today that it plans to distribute subscription rights ("Rights") to the holders of its common shares...
